Grifols Plasma Center Campaign

The Immunodeficiency Foundation (IDF) thanked Gulforth and its plasma centers and plasma donors for their support. Your donation will help the Israeli Defense Forces provide resources and services to thousands of people with primary immunodeficiency disease.

IDF is a 501 (c) (3) non-profit organization and your donation can be tax exempt to the extent permitted by IRS regulations. Please consult your tax adviser to decide tax reduction for your contribution

Grifols was founded in 1940 by Dr. José Antonio Milifols Lucas in Barcelona, ​​Spain. Since then, Griffols has been at the forefront of the plasma industry and a pioneer of complex technologies for chemical recovery, inspection and manufacture derived from plasma today. Over the years we have built a network of the world's largest plasma donor centers and have made Grifols the world leader in plasma collection and world leader in plasma derived drugs. Our commitment to serve people is the center of everything we do. That is why we are trying hard to recruit talented people and create a vibrant and lively organization. As a company, we are proud to guarantee the quality, integrity and safety of everything we do - this is our center. After all, our products are crucial to the quality and health of the patients we serve.

For large companies in the industry, there are Grifols, CSL, Octapharma, which make up the majority of plasma. Shire is a larger and more diverse biopharmaceutical company. The United States is important for the continued success and growth of these companies. As the world's largest plasma producer, the US supplies 70% of the world's plasma, but it supplies only 40% of world demand. Production is accelerating growth. For example, Gulfor is planning to expand to 225 donation centers from 171 in 2016 to 80 in 2010 in the coming years. The company 's earnings have increased six - fold between 2006 and 2016, and other companies are growing as well; as of 2015 Grifols is collecting 26,000 donations a day. The company managed about one-fifth of the plasma treatment market in 2016.

In contacting this article, Shire pointed out the medical importance of plasma therapy, but refrained from describing how the industry works. Neither Grifols nor CSL answered the comment request, and Octapharma introduced us to the industry association Plasma Protein Therapy Association, which said it can not comment on its member companies' business prospects or donor compensation practices. These enterprise expansion plans not only stick to the continuous demand of the plasma, there are also many potential donors that can actually use additional funds. The framework of CSL Plasma's website can "help people around the world to live a healthier and happier life" - There is a selfless reason to donate blood.